Table 1. Baseline patient... | American Society of Hematology

Table 1.

Baseline patient characteristics

Variable	Total		BM biopsy
	Total		Negative		Positive
	n	%	n	%	n	%
Total	311	100.0	212	100.0	99	100.0
Age
<70	217	69.8	156	73.6	61	61.6
≥70	94	30.2	56	26.4	38	38.4
Race
White	276	88.7	183	86.3	93	93.9
Black	21	6.8	17	8.0	4	4.0
Other	6	1.9	5	2.4	1	1.0
Not available	8	2.6	7	3.3	1	1.0
Ethnicity
Hispanic/Latino	43	13.8	32	15.1	11	11.1
Non-Hispanic	264	84.9	178	84.0	86	86.9
Not available	4	1.3	2	0.9	2	2.0
Stage
I-II	144	46.3	144	67.9	—	—
III-IV	167	53.7	68	32.1	99	100.0
LDH
Normal	185	59.5	131	61.8	54	54.5
Elevated	56	18.0	27	12.7	29	29.3
Not available	70	22.5	54	25.5	16	16.2
B symptoms
No	246	79.1	175	82.5	71	71.7
Yes	60	19.3	33	15.6	27	27.3
Not available	5	1.6	4	1.9	1	1.0
BM PET/CT
Negative	273	87.8	210	99.1	63	63.6
Positive	38	12.2	2	0.9	36	36.4

Variable	Total		BM biopsy
	Total		Negative		Positive
	n	%	n	%	n	%
Total	311	100.0	212	100.0	99	100.0
Age
<70	217	69.8	156	73.6	61	61.6
≥70	94	30.2	56	26.4	38	38.4
Race
White	276	88.7	183	86.3	93	93.9
Black	21	6.8	17	8.0	4	4.0
Other	6	1.9	5	2.4	1	1.0
Not available	8	2.6	7	3.3	1	1.0
Ethnicity
Hispanic/Latino	43	13.8	32	15.1	11	11.1
Non-Hispanic	264	84.9	178	84.0	86	86.9
Not available	4	1.3	2	0.9	2	2.0
Stage
I-II	144	46.3	144	67.9	—	—
III-IV	167	53.7	68	32.1	99	100.0
LDH
Normal	185	59.5	131	61.8	54	54.5
Elevated	56	18.0	27	12.7	29	29.3
Not available	70	22.5	54	25.5	16	16.2
B symptoms
No	246	79.1	175	82.5	71	71.7
Yes	60	19.3	33	15.6	27	27.3
Not available	5	1.6	4	1.9	1	1.0
BM PET/CT
Negative	273	87.8	210	99.1	63	63.6
Positive	38	12.2	2	0.9	36	36.4

LDH, lactate dehydrogenase.